Search Results

There are 21241 results for: content related to: Australasian multicentre phase II study of paclitaxel (Taxol * ) in relapsed ovarian cancer

  1. Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis

    International Journal of Cancer

    Volume 137, Issue 8, 15 October 2015, Pages: 2029–2039, Xiaoqian Yang, Jacson Shen, Yan Gao, Yong Feng, Yichun Guan, Zhan Zhang, Henry Mankin, Francis J. Hornicek and Zhenfeng Duan

    Version of Record online : 5 MAY 2015, DOI: 10.1002/ijc.29574

  2. You have free access to this content
    P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2439–2447, Jeroen J.M.A. Hendrikx, Jurjen S. Lagas, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen and Alfred H. Schinkel

    Version of Record online : 14 NOV 2012, DOI: 10.1002/ijc.27912

  3. Paclitaxel (Taxol)

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 14, Issue 1, January-February 1994, Pages: 3–34, David R. Kohler and Barry R. Goldspiel

    Version of Record online : 18 JAN 2012, DOI: 10.1002/j.1875-9114.1994.tb02785.x

  4. You have free access to this content
    Local delivery of paclitaxel in the treatment of peripheral arterial disease

    European Journal of Clinical Investigation

    Volume 45, Issue 3, March 2015, Pages: 333–345, Vivian G. Ng, Carlos Mena, Cody Pietras and Alexandra J. Lansky

    Version of Record online : 14 FEB 2015, DOI: 10.1111/eci.12407

  5. Clinical Overview of the Taxanes

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 5P2, September-October 1997, Pages: 110S–125S, Barry R. Goldspiel

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03813.x

  6. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 10, October 2013, Pages: 3748–3761, Firat Yerlikaya, Aysegul Ozgen, Imran Vural, Olgun Guven, Ergun Karaagaoglu, Mansoor A. Khan and Yilmaz Capan

    Version of Record online : 5 AUG 2013, DOI: 10.1002/jps.23686

  7. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 507–514, C.J. POOLE, T. PERREN, S. GAWANDE, M. RIDDERHEIM, J. COOK, A. JENKINS and D. ROYCHOWDHURY

    Version of Record online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00466.x

  8. Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis

    European Journal of Cancer Care

    L. Peng, Z. Bu, X. Ye, Y. Zhou and Q. Zhao

    Version of Record online : 4 NOV 2015, DOI: 10.1111/ecc.12407

  9. Abstracts

    International Journal of Gynecological Cancer

    Volume 14, Issue s1, September 2004, Pages: 1–249,

    Version of Record online : 13 SEP 2004, DOI: 10.1111/j.1525-1438.2004.1315431.x

  10. Pharmaceutical and physical properties of paclitaxel (taxol) complexes with cyclodextrins

    Journal of Pharmaceutical Sciences

    Volume 84, Issue 10, October 1995, Pages: 1223–1230, Uma S. Sharma, Sathyamangalam V. Balasubramanian and Robert M. Straubinger

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600841015

  11. Paclitaxel-Loaded Stabilizer-Free Poly(D,L-lactide-co-glycolide) Nanoparticles Conjugated with Quantum Dots for Reversion of Anti-Cancer Drug Resistance and Cancer Cellular Imaging

    Journal of the Chinese Chemical Society

    Volume 56, Issue 5, October 2009, Pages: 923–934, Wen-Shuo Kuo, Yu-Cian Ku, Hei-Tin Sei, Fong-Yu Cheng and Chen-Sheng Yeh

    Version of Record online : 25 SEP 2013, DOI: 10.1002/jccs.200900136

  12. Flow Cytometric Identification of Paclitaxel-Accumulating Subpopulations

    Biotechnology Progress

    Volume 21, Issue 3, 2005, Pages: 978–983, Michael C. Naill and Susan C. Roberts

    Version of Record online : 5 SEP 2008, DOI: 10.1021/bp049544l

  13. Liquid–liquid extraction for recovery of paclitaxel from plant cell culture: Solvent evaluation and use of extractants for partitioning and selectivity

    Biotechnology Progress

    Volume 28, Issue 4, July/August 2012, Pages: 990–997, Timothy J. McPartland, Rohan A. Patil, Michael F. Malone and Susan C. Roberts

    Version of Record online : 18 JUN 2012, DOI: 10.1002/btpr.1562

  14. A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer

    International Journal of Gynecological Cancer

    Volume 17, Issue 2, March/April 2007, Pages: 379–386, A.L. LEISER, F.C. MALUF, D.S. CHI, P. SABBATINI, M.L. HENSLEY, L. SCHWARTZ, E. VENKATRAMAN, D. SPRIGGS and C. AGHAJANIAN

    Version of Record online : 6 MAR 2007, DOI: 10.1111/j.1525-1438.2007.00811.x

  15. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity

    The Journal of Pathology

    Volume 226, Issue 4, March 2012, Pages: 666–673, Xiaodong Sun, Dengwen Li, Yunfan Yang, Yuan Ren, Jingyu Li, Zaizhu Wang, Bin Dong, Min Liu and Jun Zhou

    Version of Record online : 17 JAN 2012, DOI: 10.1002/path.3026

  16. Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel

    Journal of Biomedical Materials Research Part A

    Volume 92A, Issue 4, 15 March 2010, Pages: 1283–1291, Ariella Shikanov, Boris Vaisman, Sergey Shikanov and Abraham J. Domb

    Version of Record online : 2 APR 2009, DOI: 10.1002/jbm.a.32429

  17. You have full text access to this Open Access content
    Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen

    Cancer Science

    Volume 103, Issue 4, April 2012, Pages: 821–827, Mingli Xu, Masakatsu Takanashi, Kosuke Oikawa, Hirotaka Nishi, Keiichi Isaka, Takayuki Yoshimoto, Junko Ohyashiki and Masahiko Kuroda

    Version of Record online : 4 MAR 2012, DOI: 10.1111/j.1349-7006.2012.02221.x

  18. Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes

    Arthritis & Rheumatism

    Volume 40, Issue 6, June 1997, Pages: 1073–1084, A. Hui, G. V. Kulkarni, W. L. Hunter, C. A. G. McCulloch and T. F. Cruz

    Version of Record online : 12 DEC 2005, DOI: 10.1002/art.1780400612

  19. Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens

    International Journal of Gynecological Cancer

    Volume 15, Issue 2, March 2005, Pages: 240–245, R. Uslu, U.A. Sanli, Y. Dikmen, B. Karabulut, A. Ozsaran, C. Sezgin, G.G. Muezzinoglu, S.B. Omay and E. Goker

    Version of Record online : 18 MAR 2005, DOI: 10.1111/j.1525-1438.2005.15210.x

  20. Radiation sensitization of chinese hamster V79 cells by paclitaxel

    Radiation Oncology Investigations

    Volume 1, Issue 2, 1993, Pages: 103–110, John A. Cook, William Degraff, Diane Teague and James K. Liebmann

    Version of Record online : 18 JUL 2006, DOI: 10.1002/roi.2970010205